TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11834139

Group type: EXPERIMENTAL
Intervention: Regular ingestion of black tea (5 cups per day for 4 weeks)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Hot water ingestion (control)
Number of subjects: 21
Study: 10825861

Group type: EXPERIMENTAL
Intervention: New toothbrush bristle arrangement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional V-shaped toothbrush
Number of subjects: 0

Group type: COMPARATOR
Intervention: Flat-headed toothbrush
Number of subjects: 0
Study: 7584704

Group type: EXPERIMENTAL
Intervention: Oral ethinyl estradiol at a dose of 100 ng/kg/day
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Transdermal 17 beta‐estradiol via adhesive skin patch at 0.0125 mg/kg/day
Number of subjects: 8
Study: 1980660

Group type: EXPERIMENTAL
Intervention: 200 mg metoprolol (long-acting)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 200 mg metoprolol + 120 mg ISDN (sustained-release)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 200 mg metoprolol + 120 mg diltiazem (sustained-release)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 200 mg metoprolol + 10 mg nisoldipine
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 200 mg metoprolol + 120 mg ISDN + 120 mg diltiazem
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 200 mg metoprolol + 120 mg ISDN + 10 mg nisoldipine
Number of subjects: 11
Study: 371663

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 28
Study: 6841564

Group type: EXPERIMENTAL
Intervention: Diazepam (3 days treatment)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 30085178

Group type: EXPERIMENTAL
Intervention: High-dose SP strain vaccine
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: Low-dose SP strain vaccine
Number of subjects: 1080

Group type: COMPARATOR
Intervention: High-dose S79 vaccine
Number of subjects: 1080

Group type: COMPARATOR
Intervention: Low-dose S79 vaccine
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1080
Study: 29966667

Group type: EXPERIMENTAL
Intervention: Stable state
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Exacerbation
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Follow-up 4 weeks after exacerbation
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Severe exacerbation
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: C1M, C4Ma3, C4M2
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: None of the biomarkers
Number of subjects: 498
Study: 27935886

Group type: EXPERIMENTAL
Intervention: Detralex (micronized purified flavonoid fraction) at a daily dose of 1,000 mg for 2 weeks prior to sclerotherapy and for at least 2 months after the procedure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control Group (no drug)
Number of subjects: 60
Study: 24586327

Group type: EXPERIMENTAL
Intervention: PRISM intervention (community-based support program)
Number of subjects: 7169

Group type: COMPARATOR
Intervention: Comparison arm (no intervention)
Number of subjects: 7169
Study: 22782376

Group type: EXPERIMENTAL
Intervention: High-energy extracorporeal shock wave therapy (ESWT)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Modified endoscopic plantar fasciotomy
Number of subjects: 65
Study: 21048483

Group type: EXPERIMENTAL
Intervention: TimeSlips intervention (twice-weekly for 6 weeks)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 56
Study: 17237006

Group type: EXPERIMENTAL
Intervention: Surgery alone for stages I and IIa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (CT) or chemoradiation (CRT) followed by surgery for stage IIb
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant CT or CRT followed by surgery for locally advanced adenocarcinomas (stage III)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exclusive CRT for locally advanced squamous cell carcinomas (stage III)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant surgery in experienced centres for selected patients
Number of subjects: 0
Study: 15708211

Group type: EXPERIMENTAL
Intervention: Sentences with semantically complex verbs (e.g., causatives)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Semantically and morphologically complex verbs
Number of subjects: 140
Study: 12109920

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 825

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 825
Study: 10391659

Group type: EXPERIMENTAL
Intervention: PROSQOLI
Number of subjects: 0

Group type: COMPARATOR
Intervention: EORTC QLQ-C30
Number of subjects: 0

Group type: COMPARATOR
Intervention: QLM-P14
Number of subjects: 0
Study: 7751684

Group type: EXPERIMENTAL
Intervention: Intranasal bovine parainfluenza virus type 3 (BPIV‐3) vaccine
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 1968773

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Adrenergic agonists (Clonidine and Guanfacine)
Number of subjects: 90
Study: 107908

Group type: EXPERIMENTAL
Intervention: Protirelin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31143445

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements with added high-dose vitamins and minerals (LNS-VM)
Number of subjects: 1752

Group type: COMPARATOR
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 1752
Study: 29735881

Group type: EXPERIMENTAL
Intervention: EMLA cream plus Vapocoolant spray
Number of subjects: 90

Group type: COMPARATOR
Intervention: Lidocaine spray
Number of subjects: 90

Group type: COMPARATOR
Intervention: EMLA cream only
Number of subjects: 90
Study: 26686336

Group type: EXPERIMENTAL
Intervention: SPECT study
Number of subjects: 2381

Group type: EXPERIMENTAL
Intervention: PET study
Number of subjects: 2381

Group type: EXPERIMENTAL
Intervention: Quality score
Number of subjects: 2381

Group type: COMPARATOR
Intervention: Adherence to best practices
Number of subjects: 2381

Group type: EXPERIMENTAL
Intervention: Best practices
Number of subjects: 2381
Study: 24934986

Group type: EXPERIMENTAL
Intervention: Doxycycline plus rifampicin for 6 weeks and streptomycin for the first 7 days
Number of subjects: 144

Group type: COMPARATOR
Intervention: Doxycycline plus rifampicin for 8 weeks and streptomycin for 7 days
Number of subjects: 144
Study: 22335487

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 20678684

Group type: COMPARATOR
Intervention: Midazolam 7.5 mg alone (treatment A)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Midazolam 7.5 mg with zibotentan 10 mg once daily (treatment B)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Zibotentan 10 mg once daily
Number of subjects: 12
Study: 17426305

Group type: EXPERIMENTAL
Intervention: Extended program (24 hours of education, 28 hours of support groups)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Compressed strategy (16 hours of education, 6 hours of support groups)
Number of subjects: 216
Study: 15711832

Group type: EXPERIMENTAL
Intervention: Triflusal 900 mg single oral dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triflusal 600 mg once daily for 14 days
Number of subjects: 0
Study: 12742469

Group type: EXPERIMENTAL
Intervention: sirolimus plus mycophenolate mofetil (group A)
Number of subjects: 180

Group type: COMPARATOR
Intervention: sirolimus plus cyclosporine (group B)
Number of subjects: 180
Study: 10396905

Group type: EXPERIMENTAL
Intervention: Wavelet Networks (WN) single-sweep analysis
Number of subjects: 50

Group type: COMPARATOR
Intervention: Averaged ERP analysis
Number of subjects: 50
Study: 7475821

Group type: EXPERIMENTAL
Intervention: Barrett's oesophagus patients (n = 104)
Number of subjects: 641

Group type: COMPARATOR
Intervention: Controls (n = 537)
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Patients older than 59
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Family history of colorectal cancer
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Rectal bleeding
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Previous colonic investigation
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Complete colonoscopy
Number of subjects: 641
Study: 2137653

Group type: EXPERIMENTAL
Intervention: RATG (polyclonal)
Number of subjects: 82

Group type: COMPARATOR
Intervention: OKT3 (monoclonal)
Number of subjects: 82
Study: 6986236

Group type: EXPERIMENTAL
Intervention: Clocortolone pivalate 0.1 percent cream
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo cream base
Number of subjects: 100
Study: 31314651

Group type: EXPERIMENTAL
Intervention: Parental Occupation Executive Training (POET)
Number of subjects: 72
Study: 30694582

Group type: EXPERIMENTAL
Intervention: HepCATT intervention (placement of a half-time facilitator in clinics for 12 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HepCATT intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control clinics (no intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control clinics
Number of subjects: 0
Study: 29561497

Group type: EXPERIMENTAL
Intervention: +2.50 D add Biofinity Multifocal 'D' MFCLs
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Best-corrected MFCLs
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Photopic pupil size
Number of subjects: 294
Study: 27283929

Group type: EXPERIMENTAL
Intervention: Hemin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 24284781

Group type: EXPERIMENTAL
Intervention: etravirine
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: efavirenz
Number of subjects: 193
Study: 22422428

Group type: EXPERIMENTAL
Intervention: Cognitive Geriatric Unit (CGU)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional Geriatric Care (non-CGU)
Number of subjects: 96
Study: 19228235

Group type: EXPERIMENTAL
Intervention: Psychosocial support for cancer survivors and families
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General well-being support for families
Number of subjects: 0
Study: 17488660

Group type: EXPERIMENTAL
Intervention: C.E.R.A. 1.0-4.2 mg/kg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: C.E.R.A. 2.0-8.0 mg/kg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: C.E.R.A.
Number of subjects: 64
Study: 15015070

Group type: EXPERIMENTAL
Intervention: IVCP (500 mg/m² per month IV for 6 months)
Number of subjects: 47

Group type: COMPARATOR
Intervention: OCP (2 mg/kg per day for 12 weeks)
Number of subjects: 47
Study: 11235791

Group type: EXPERIMENTAL
Intervention: Volvo 'WHIPS' seat
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Dynamic seat test
Number of subjects: 3

Group type: COMPARATOR
Intervention: Seat properties (geometry, stiffness, energy absorption)
Number of subjects: 3
Study: 9678536

Group type: EXPERIMENTAL
Intervention: Bororos
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rural people
Number of subjects: 0

Group type: COMPARATOR
Intervention: Italian population
Number of subjects: 0
Study: 7850992

Group type: EXPERIMENTAL
Intervention: Electrophoresis method for detecting Lp(a)
Number of subjects: 719

Group type: COMPARATOR
Intervention: Electroimmunoassay for Lp(a)
Number of subjects: 719
Study: 3289737

Group type: EXPERIMENTAL
Intervention: 1 mg/m2 monoclonal anti-carcinoembryonic antigen (CEA) antibody, NP-2, administered three times weekly or once a week for 12 to 240 days (5 to 13 injections)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Blocking radioimmunoassay using [125I]NP-2-F(ab')2
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Longitudinal studies
Number of subjects: 10
Study: 28478985

Group type: EXPERIMENTAL
Intervention: Aluminum chloride paste (group P)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cord and aluminum chloride paste (group CP)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Double-cord technique (group C)
Number of subjects: 67
Study: 27461451

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercise with private consultations, educational DVDs and pamphlets
Number of subjects: 52

Group type: COMPARATOR
Intervention: Routine postoperative care (Control)
Number of subjects: 52
Study: 25247728

Group type: EXPERIMENTAL
Intervention: Cognitive/affective/behavioral intervention involving college swim team members working with 8 Special Olympics swimmers over 4 sessions in 6 weeks.
Number of subjects: 33

Group type: COMPARATOR
Intervention: No-intervention control group (N = 17).
Number of subjects: 33
Study: 22795879

Group type: EXPERIMENTAL
Intervention: Trabecular Metal Cone (TM Cone)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No TM Cone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (TM Cone and No TM Cone)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TM Cone
Number of subjects: 40
Study: 20601412

Group type: EXPERIMENTAL
Intervention: Transdermal testosterone (50 mg) daily for 6 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo gel daily for 6 months
Number of subjects: 30
Study: 18694901

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine (13.2 to 39.0 mug/kg per day in 3 divided doses)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard-of-care oral neonatal opium solution
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine
Number of subjects: 26
Study: 15919772

Group type: EXPERIMENTAL
Intervention: SR misoprostol 800 microg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional misoprostol 400 microg
Number of subjects: 30

Group type: COMPARATOR
Intervention: SR misoprostol 400 microg
Number of subjects: 30
Study: 12612897

Group type: EXPERIMENTAL
Intervention: NCX-4016 (400 and 800 mg twice daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aspirin (200 and 420 mg twice daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10234582

Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg/day) and calcium carbonate (500 mg/day)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Calcium carbonate alone
Number of subjects: 26
Study: 8690689

Group type: EXPERIMENTAL
Intervention: Guilty participants who received countermeasure instructions
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Guilty participants who received countermeasure instructions and were allowed to practice the countermeasures
Number of subjects: 4

Group type: COMPARATOR
Intervention: Guilty controls who committed the mock crime but received no countermeasure instructions
Number of subjects: 4

Group type: COMPARATOR
Intervention: Innocent participants who were not involved in the mock crime
Number of subjects: 4
Study: 8315230

Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Pelvic muscle exercise
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control
Number of subjects: 135
Study: 3826200

Group type: EXPERIMENTAL
Intervention: Clonidine transdermal therapeutic system
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 30460981

Group type: EXPERIMENTAL
Intervention: Low-dose intravenous haloperidol (0.5 mg three times daily for a total of 11 doses)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Low-dose intravenous haloperidol (0.5 mg three times daily for a total of 11 doses) in esophagectomy subgroup
Number of subjects: 135
Study: 28550338

Group type: EXPERIMENTAL
Intervention: Modified transcanalicular dacryocystorhinostomy (MT-DCR)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional transcanalicular dacryocystorhinostomy (T-DCR)
Number of subjects: 44
Study: 25804628

Group type: EXPERIMENTAL
Intervention: Learner-centered diabetes self-management education (DSME) in the emergency department.
Number of subjects: 0
Study: 23910226

Group type: EXPERIMENTAL
Intervention: CBC-based prognostic index
Number of subjects: 3237

Group type: COMPARATOR
Intervention: TNM system
Number of subjects: 3237
Study: 21989186

Group type: EXPERIMENTAL
Intervention: Panitumumab + FOLFOX4
Number of subjects: 1106

Group type: EXPERIMENTAL
Intervention: Panitumumab + FOLFIRI
Number of subjects: 1106

Group type: COMPARATOR
Intervention: FOLFOX4
Number of subjects: 1106

Group type: COMPARATOR
Intervention: FOLFIRI
Number of subjects: 1106
Study: 19341446

Group type: EXPERIMENTAL
Intervention: 3 microg intradermal vaccine
Number of subjects: 1150

Group type: EXPERIMENTAL
Intervention: 6 microg intradermal vaccine
Number of subjects: 1150

Group type: EXPERIMENTAL
Intervention: 9 microg intradermal vaccine
Number of subjects: 1150

Group type: COMPARATOR
Intervention: 15 microg intramuscular vaccine
Number of subjects: 1150

Group type: EXPERIMENTAL
Intervention: Intramuscular and intradermal vaccinations
Number of subjects: 1150
Study: 17014279

Group type: EXPERIMENTAL
Intervention: Skin cancer prevention intervention
Number of subjects: 1788
Study: 12969534

Group type: EXPERIMENTAL
Intervention: Accelerated fractionated radiotherapy (AF group, n=138, 6 fractions per week, 180‐190 cGy per day, total dose 7,400‐7,600 cGy)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Accelerated fractionated radiotherapy with concurrent chemotherapy (AFC group, n=139, 6 fractions per week, 180‐190 cGy per day, total dose 7,400‐7,600 cGy, cisplatin and 5‐FU one time per week)
Number of subjects: 416

Group type: COMPARATOR
Intervention: Conventional fractionated radiotherapy (CF group, n=139, 5 fractions per week, 200 cGy per day, total dose 7,000‐7,600 cGy)
Number of subjects: 416
Study: 10935809

Group type: EXPERIMENTAL
Intervention: Frozen cultured human allogeneic epidermal sheets
Number of subjects: 11

Group type: COMPARATOR
Intervention: Petrolatum-coated gauze (control)
Number of subjects: 11
Study: 8944932

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis dose (KprT/V) ranging from 1.5 to 2.3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis with (KprT/V)ud = 2.00
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Predicted decrease in renal urea clearance (KrT/V)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maximum (KprT/V)ud level achieved in CANUSA
Number of subjects: 0
Study: 1683559

Group type: EXPERIMENTAL
Intervention: 800 micrograms ropinirole preceded by 20 mg domperidone
Number of subjects: 9

Group type: COMPARATOR
Intervention: 800 micrograms ropinirole
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 20 mg domperidone
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 20 mg domperidone followed by ropinirole-placebo
Number of subjects: 9
Study: 7202230

Group type: EXPERIMENTAL
Intervention: Sinemet plus benztropine mesylate
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sinemet plus placebo
Number of subjects: 29
Study: 31475296

Group type: EXPERIMENTAL
Intervention: Sacubitril-valsartan (target dosage, 97/103 mg twice daily)
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: Sacubitril-valsartan
Number of subjects: 464

Group type: COMPARATOR
Intervention: Enalapril (target dosage, 10 mg twice daily)
Number of subjects: 464

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 464
Study: 28662338

Group type: EXPERIMENTAL
Intervention: Couples' relationship enrichment program (5 sessions)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study: 25752834

Group type: EXPERIMENTAL
Intervention: Rituximab treatment (single infusion)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Steroid therapy
Number of subjects: 0
Study: 23339809

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT) adherence within the first month
Number of subjects: 2997

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT) adherence during 1-6 months
Number of subjects: 2997

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT) adherence during 6-12 months
Number of subjects: 2997

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT) adherence beyond one year
Number of subjects: 2997
Study: 20869329

Group type: EXPERIMENTAL
Intervention: Roux‐en‐Y gastric bypass
Number of subjects: 44
Study: 19919396

Group type: EXPERIMENTAL
Intervention: Bupropion (BUP) 150-300 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (TN) 21 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bupropion combined with transdermal nicotine (BUP+TN)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (C) - no drugs
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo group (PL)
Number of subjects: 24
Study: 16890574

Group type: EXPERIMENTAL
Intervention: Ritonavir (300 mg twice daily for 2 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ritonavir
Number of subjects: 20
Study: 15310632

Group type: EXPERIMENTAL
Intervention: Sevoflurane 8%, N(2)O 67% and iv remifentanil 1 to 1.5 microg.kg(‐1)
Number of subjects: 156

Group type: COMPARATOR
Intervention: iv fentanyl 2 to 3 microg.kg(‐1), propofol 2 mg.kg(‐1), and rocuronium 0.3 to 0.5 mg.kg(‐1)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Sevoflurane‐remifentanil induction
Number of subjects: 156
Study: 11742191

Group type: EXPERIMENTAL
Intervention: Budesonide (6, 9, or 18 mg daily)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Control group (steroid pretreatment)
Number of subjects: 318
Study: 9204361

Group type: EXPERIMENTAL
Intervention: Iopentol (Imagopaque 350)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Metrizoate (Isopaque Coronar 370)
Number of subjects: 82
Study: 8052507

Group type: EXPERIMENTAL
Intervention: 60 mg/kgbw Biltricide (Group 1)
Number of subjects: 35

Group type: COMPARATOR
Intervention: 40 mg/kgbw (Group 2) - 12 Biltricide, 10 Distocide
Number of subjects: 35
Study: 3148130

Group type: EXPERIMENTAL
Intervention: Carbaryl lotion
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Malathion solution
Number of subjects: 268

Group type: COMPARATOR
Intervention: Pyrethrin shampoo
Number of subjects: 268

Group type: COMPARATOR
Intervention: Pyrethroid spray
Number of subjects: 268

Group type: COMPARATOR
Intervention: Carbaryl shampoo
Number of subjects: 268